ALL RESULTS
Showing 1-4 of 4 results
Biopharma Modalities VC Trends: Selective Bets as Investors Seek De-Risked Opportunities
Biopharma modalities' venture capital (VC) investments are becoming more selective, favoring proven assets over high-risk innovation. While cardiometabolic drugs and AI-driven drug discovery continue to attract capital, investors are shifting...
Blogs
Private Equity Firms Are Leveraging Data and Analytics to Manage Their Portfolio
Private equity (PE) firms' business practices have been transformed by demanding higher competition, escalating resources, and demanding more transparency from their investors. Many private equity firms are turning to the use...
Blogs